Shore Operating Partners bridge the financial expertise of Shore investment professionals with the operating and strategic needs of our portfolio companies. Shore Operating Partners represent leaders of their respective fields and facilitate the implementation of value creation strategies through past experience and a deep network of industry relationships.
Kush Agarwal currently serves as a board member and strategic advisor of Vein Clinics of America after serving as President and CEO for over 20 years. Kush also serves as a member of the Board of Directors of United Vision Partners, a private equity backed multi-site ophthalmology platform based in Minnesota. During his time as CEO, Vein Clinics of America grew from 3 centers to over 25 centers across 10 states. In addition, Mr. Agarwal served on the board of directors of IntegraMed America upon their acquisition of Vein Clinics of America in August 2007.
Hilarie Aitken is the CEO and Co-Owner at Navia Benefits Solutions and has been an integral part of the vision and growth of Navia for over 16 years. Her passion and expertise in the field have been a driving force in the expansion of consumer driven employee benefits throughout the region. Hilarie graduated from the University of Washington with a major in Political Science and a minor in Communications. She has served on the board of the Northwest Washington Association of Health Underwriters (NWAHU) and Employer Council on Flexible Compensation (ECFC), a national industry organization where she headed up the Education Committee. Hilarie enjoys sharing her passion, stories and experience to human resource professionals and consultants at various speaking engagements.Current and Past Board RolesPoint CNavia Benefit SolutionsAreas of FocusThird-Party Administration
Jim currently serves on the Board of Directors of Nova Health. Jim is currently the Chief Operating Officer at Banfield Pet Hospitals, a nationwide provider of general veterinary services. Prior to his current position at Banfield, Jim served as President and CEO of CareMeridian, where he oversaw nursing and rehabilitative facilities. Jim draws from a deep background comprising of multi-site healthcare, business development, and data analytics.
Michael currently serves on the Board of Directors of Mission Veterinary Partners, Golden Bear Therapy Partners, and Together Women's Health, Shore Capital portfolio companies. Michael is a co-founder of MD Holdings, an entrepreneur-owned holding company formed to acquire and grow a limited number of businesses with significant growth potential. From 2015—2017, Mr. Aubrey was Chief Executive Officer of StatLab Medical Products and successfully led the company through its sale to Cressey & Company. Prior to being appointed CEO, Michael served as Co-President of StatLab Medical Products from 2009 to 2015, where he had oversight of the company’s sales, marketing, product development, and technical support capabilities. Under Michael’s leadership, StatLab’s equity value increased 10x+ and the Company established itself as the premier anatomic pathology supplier in the United States. Prior to acquiring StatLab Medical Products, Michael was CEO of a parking lot facility management company where he grew facility revenues under management from $3 million to $20 million and headcount from 25 to 125 in less than five years. Michael also sits on the Boards of StatLab Medical Products, MedCerts, LLC., and Delasco Dermatological Supply Company.
Tom Bailey is a board member of SCP Interventional Radiology, a Shore Capital portfolio company. Tom joined NanoString Technologies as CFO in January 2018. He was formerly the CFO of Agamatrix and previously served as President and CEO for Angiotech Pharmaceuticals, Inc. until the fall of 2013, at which time he transitioned to Angiotech’s board. As CEO of Angiotech, Tom led the company through a successful operational restructuring, and concluded the sale of one of Angiotech’s two medical device products businesses, generating significant returns for Angiotech’s shareholders. Prior to being named Angiotech’s CEO in the fall of 2011, Tom served for six years as Angiotech’s CFO, and for two years as its Vice President of Business Development. Prior to Angiotech, Tom worked as an investment banker in the life sciences practice group at Credit Suisse First Boston and Donaldson, Lufkin & Jenrette.
Nathan Bard is a Board of Directors Member at Column Health, Shore Capital's second medication-assisted treatment platform investment. Nate currently leads ATI’s growth function, serving as its Chief Growth Officer. In this role, he is responsible for sales, marketing, mergers, acquisitions, and new clinic growth and openings. Nate joined ATI in 2014, bringing a background in private equity and investment banking experience. Originally from Michigan, Bard is a graduate of the University of Notre Dame with a degree in Finance. With a combination of strategic and financial expertise, Nate has helped ATI expand its acquisition capabilities with an analytical approach to decision making
David Barr is a Board of Directors Member at Column Health, Shore Capital's second medication-assisted treatment platform investment. David currently serves as Chairman of PMTD Restaurants as well as Managing Director of Franworth, a professional services firm for and investor in franchise businesses. In connection with IFA, Barr has met with the White House, senators, congressmen and their staffs to discuss the impact of ACA on restaurant jobs. In addition, Barr has spoken about healthcare on Fox News, Fox & Friends, CNN Online, and his experiences have been written about by New York Times, International Business Times, and the Washington Examiner. David is the former Chairman of the International Franchise Association and has significant experience in opening retail locations through his involvement with Del Frisco’s Restaurant Group, Capriotti’s Sandwich Shops, Mrs. Fields and TCBY, the Jewelry Group, Pizza Hut, and several other consumer-retail businesses. David Barr began his career in Atlanta with Pricewaterhouse Coopers after attending the University of Virginia.
Dylan Bates currently serves on the Southern Veterinary Partners Board of Directors. Dylan is the Chief Executive Officer and President of ATI Physical Therapy Holdings, LLC (“ATI”) and also sits on ATI’s Board of Directors. Dylan joined ATI in 1999 to expand physical therapy services and has seen the company grow from 1 location in Illinois to nearly 300 locations across 10 states. ATI has undergone three private equity investments. It was initially bought by KRG Capital, a Denver-based private equity firm, in 2005, then sold to GTCR, a Chicago-based private equity firm in March 2010, and then repurchased by KRG in December 2012. Dylan is a licensed Physical Therapist with extensive experience in multi-site healthcare services and operations.
Terry Bauer currently serves on the Board of Directors for Specialdocs Consultants. As a Principal at Stroudwater Associates, an Atlanta-based management consultancy, Terry lends his expertise to the Affiliations and Partnerships and Physician-Hospital Alignment practices. Terry is adept at developing, communicating and executing enterprise-wide processes and procedures to improve performance, streamline operations, and deliver bottom-line results. Previously, Terry served as CEO of Bauer Health, LLC, following a long career as Co-Founder, President, CEO, and Director of Orion HealthCorp. Terry is also a member of the Atlanta CEO Council, Young Presidents Organization and Atlanta Technology Village.
George has over 30 years of experience in the packaging industry and has served in several roles over his career. George currently serves as a principal at Whitehall Investors and CEO Advisory Group. George’s prior experience includes roles as Co-Chairman of U.S. Can Corporation, Chairman and Chief Executive Officer of Altivity Packaging, and Chief Executive Officer of Ivex Packaging.
Greg Bell is the founder and CEO of Expansion Health, a technology to help health systems deliver multiple digital patient services into a single mobile app. Greg has over 35+ years building successful businesses in healthcare. Prior to Expansion Health, he founded HealthX, one of the first cloud-based technology companies in healthcare, and grew the business to the largest healthcare portal provider for U.S. health plans and payors. Prior, Greg also founded First Benefit Corp in 1982 and grew the company to one of the largest TPAs in the country in five years. Greg has a reputation for building solid teams that deliver exceptional healthcare services.
Dave has forty years of experience in food & beverage and CPG. Dave began his career at Procter & Gamble where he spent twenty-four years in product supply and supply chain management. In 2005 he joined the Campbell Soup Company where he served in several key supply chain leadership roles prior to assuming responsibility for the company’s global supply chain. Currently, Dave serves as Conagra’s Chief Supply Chain Officer, a role in which he has helped drive efficiencies and growth since 2015. Dave has end-to-end supply chain responsibilities for the company, overseeing manufacturing, procurement, engineering, environmental sustainability, health and safety, plant quality, customer logistics and planning, transportation and warehousing, and aviation and real estate/facilities teams. Dave is also a member of the board of directors for Ardent Mills, a Conagra Brands joint venture and also serves on the board for World Business Chicago.
Dan Bowen is a board member of Argentum Medical, a Shore Capital portfolio company. Dan founded Dempsey Ventures, an investment firm funded by his personal capital and focused on medical products, in 2006 and serves as its Chief Executive Officer. Prior to Dempsey Ventures, he served as the President and Chief Executive Officer of Aspen Surgical. In 1999, Dan formed Aspen Surgical Products and purchased a few single-use surgical product lines from a public company. He grew that business over ten-fold and sold a majority interest to RoundTable Healthcare Partners in 2006. He began his career in the healthcare industry at Baxter Healthcare working in several positions and eventually leaving it after serving as a regional sales manager and corporate account executive.
Fletcher is currently the Head of M&A and Strategic Acquisitions for two of Shore Capital’s platform companies. Previously, he served as Vice President of Mergers and Acquisitions at ATI, where he oversaw sourcing, evaluating, negotiating and closing acquisition opportunities and joint ventures. Prior to ATI, Fletcher was an investment banker with Livingstone Partners, in both the U.S. and Europe, as well as with Brown Gibbons Lang & Company in Chicago.
Scott currently serves on the Board of Directors of Mission Veterinary Partners. Scott is currently Chief Executive Officer of Forefront Dermatology, a sponsor-backed, leading multi-state, multi-location dermatology group practice. Prior to his role at Forefront, Scott was President and Chief Operating Officer of Interdent, a dental practice management company, where his responsibilities ranged across practice operations, marketing, recruiting, acquisitions, office development and purchasing. Scott draws from a deep background comprising of multi-location operations, McKinsey consulting, Disney business development, and middle market private equity.
Michael is an entrepreneur, investor and healthcare strategist with 30 years’ experience leading technology-enabled healthcare organizations.
Bob is an accomplished healthcare and technology executive with thirty years of experience building and managing organizations to deliver long-term revenue and profit growth. He has lead or played a key role on multiple executive teams that successfully translated market needs into corporate strategy and then executed on the product, sales, marketing and client support initiatives needed to drive quantifiable business success. Bob’s key leadership experiences include working as a Manager at IBM in various marketing and sales roles in the 80's and 90's. He served in multiple executive positions at Healthx from 1999 to 2016. Healthx delivers a cloud-based Software as a Service platform serving the healthcare payer and TPA market delivering member and provider engagement solutions to drive efficiency and collaboration between health plans, providers and consumers. Bob was the Chief Growth Officer at ELAP Services, a solution provider to self-insured employers providing price transparency solutions. He has worked at High Alpha, a SaaS Venture Capital firm, in one of their portfolio companies Doxly that is focused on automating M&A transactions for large law firms. He now leads the growth strategy at Beyond Payroll, an analytics company focused on the Human Capital Management space. Bob received a Bachelor of Science in Quantitative Business Analysis from Indiana University – Kelley School of Business.
Angela currently serves on the Board of Directors of The Women’s Health Group. Angela is currently the Executive Director of Lexington Eye Associates, a physician-owned ophthalmology group based in the Boston Area. Previously, Angela served as the CEO of Northeast Dermatology Associates, one of the largest physician-owned dermatology practices in the United States and the market leader in the New England region with 15 clinical locations and more than 35 providers across Maine, Massachusetts, and New Hampshire. Prior to Northeast, Angela was a Vice President of Operations at The Dermatology Group.
Dr. Howard Chrisman is a board member of SCP Interventional Radiology, Jaffe Sports Medicine, and Together Women's Health, Shore Capital portfolio companies. Dr. Chrisman was named President of Northwestern Medical Group in October 2015. He has been on staff at the hospital since his fellowship in 1997. Dr. Chrisman also holds the roles of Interim Chair of Anesthesiology and Vice Chairman of Finance and Operations for the Feinberg School of Medicine’s Radiology Department. Furthermore, he is a professor of radiology and surgery at Feinberg.
Bill Clendenen currently serves on the Board of Directors of Navia Benefit Solutions, Nova Health, The Women’s Health Group, Together Women's Health, and Innovative Packaging Company.
Tom currently serves on the Board of Directors and as Lead Independent Director of Assembly Health. Tom is currently the Chairman of Hanger Inc., as well a Board Member at Kindred Healthcare, a provider of hospital, home health, rehabilitation, and hospice services. Prior to his role at Hanger, Tom founded Spectrum Emergency Care, a national emergency physician company. Tom draws from a deep background comprising of multi-location operations, hospital operations, mental health services operations, and medical product distribution.
Matt currently serves as a Group Vice President of Retail Operations at Meijer and has held a variety of executive management positions with the company since 2009. Prior to joining Meijer, Matt served as Vice President of Operations at Lotus Supercenters where he was responsible for creating and implementing standard operating procedures and training plans for 32,000 associates in mainland China. Before joining Lotus, Matt served in several corporate and store level leadership positions at Wal-Mart from 1999-2007. Matt currently sits on the University of San Diego Engineering School Board of Directors.
Jan Creidenberg serves as Lead Independent Director and board member of Argentum Medical, as well as board member of Innovia Medical, two of Shore Capital's portfolio companies. He most recently served as Vice President, General Manager for the Infection Prevention business of CareFusion, Inc. a global medical technology company. Jan was responsible for leading marketing initiatives in the U.S. and internationally, including currently marketed products, market research, and commercial development of new products. Jan has over 20 years of domestic and international marketing and communications experience in pharmaceuticals, healthcare and consumer brands. Jan joined Carefusion following the acquisition of Enturia Inc. where he led all aspects of marketing to successfully commercialize ChloraPrep® and related products in markets outside the United States.
Tim Danison is a co-founder and current CEO of Tabula Health. Tabula is a financial services organization focused on healthcare and reinventing the financial relationship between healthcare providers and their patients. Prior to Tabula Health, Tim was an entrepreneur and executive in various Saas/enterprise software and technology-enabled service companies. Tim has been an early-stage employee and co-founder of multiple companies throughout his career. Tim has expertise in various stages of growth including capital raising, new product development, client services realignment and organizational scaling, sales management, professional services delivery, and mergers & acquisitions. Significant and successful track record in bringing new products and services to market and creating reference clients and partner channel opportunities. From 2000 – 2007 Tim served as a Founding Member and senior executive at WageWorks (NYSE: WAGE), a leading provider of consumer directed health, commuter & employee benefit plans in the U.S.
As an Operating Partner with Shore Capital Partners, Mr. Davis is engaged as Chief Administrative Officer for the Stepping Stones Group (SSG), a nationally-recognized leader in school-based therapy and behavioral health services. SSG operates in more than 20 states across the U.S. through several brands including Cumberland Therapy Services, MyTherapyCompany, AlphaVista Services, and Staffing Options & Solutions. Prior to joining SSG, Mr. Davis was the CFO for Fast Pace Urgent Care, a Shore Capital portfolio company dedicated to providing walk-in and urgent care services to rural communities across Tennessee and Kentucky. Mr. Davis was actively involved with the growth of Fast Pace and successful sale to Revelstoke Capital Partners in August 2016. Mr. Davis initially joined the Shore Capital team in 2012 through Shore’s investment in Michigan Rehabilitation Specialists (MRS), where Matt was serving as CFO prior to Shore’s investment. MRS grew rapidly through multiple acquisitions and new clinic openings and was sold to ATI Physical Therapy in 2013. Mr. Davis also has experience working with physician practice management organizations, real estate investment groups and property management service providers through a number of entities where he held senior leadership positions. Mr. Davis obtained a B.S. in Aviation Management and General Business from Eastern Michigan University. He also received an MBA in Accounting and Finance from the University of Michigan, Stephen Ross School of Business.
Dr. Bob DeCresce currently serves on the Board of Directors of BrightView and The Women’s Health Group, Shore Capital's medication-assisted treatment and women’s health platform investments, respectively. Bob was also a member of the Board of Directors of ClearPath Diagnostics, a former Shore laboratory services portfolio company serving the women’s health industry. Bob has been Director of Clinical Laboratories at Rush University Medical Center since 1991 and serves as Chairman of the Department of Pathology at Rush Medical College in Chicago. In addition to serving on multiple lab company boards, Bob is a Director for VWR a worldwide distributor of scientific equipment and supplies with $4 billion in global sales.
Todd currently serves on the Board of Directors of Southern Veterinary Partners. Todd currently serves as President of Clear Choice Dental Implants, the largest dental implant company in the United States. Clear Choice is a twice Private Equity-backed business, first by L Catterton and then acquired by Sun Capital. Prior to his time at Clear Choice, Todd was President and CEO of Pong Research Corporation, an L Catterton backed mobile technology business.
hil Douglas is a seasoned leader who has management and board experience which spans diverse organizational settings and industries. Phil is skilled in recruiting, organizing and leading management teams to create and enhance shareholder value. His experience includes operations, restructuring, governance, marketing, finance, mergers and acquisitions, strategic and financial planning, accounting, treasury, human resources, venture capital and information technology. Phil currently serves on the Board of Directors of Oceans Healthcare, Ernest Healthcare and Breath Diagnostics. Oceans Healthcare provides inpatient and outpatient behavioral healthcare services in Texas, Louisiana and Mississippi. Ernest Healthcare is a leading provider of post-acute services. Breath Diagnostics is focused on the early detection of lung cancer through the use of its innovative and proprietary breath analysis technology. From January 2018 until August 2019 Mr. Douglas served as a Board Member and Executive Chairman of KureSmart Pain Management. The Company which is a leading provider of interventional pain management services in the Mid-Atlantic region was sold by New Harbor Capital to Nexphase Capital in August 2019.
Andy has over 20 years of experience in the flavor and ingredient industry and has worked with and developed products for some of the largest companies in the food and beverage space. Andy joined Imbibe, a beverage innovation firm, eleven years ago and serves as EVP and Chief Commercial Officer. He has led the company through transformational growth to become one of the leading beverage development and flavor companies in the U.S. Prior to his current role at Imbibe, Andy served as a Vice President of Corporate Development at Penford Corporation where he was responsible for M&A activities and led the divestiture of the company's division in Australia. Prior to his time with Penford, Andy held various leadership roles at FONA International, Sensient, and at Griffith Foods.
Kevin has over 30 years of experience in the flavor, ingredient, and broader food and beverage industry and has been a C-suite executive across many firms of varying sizes. Most recently, Kevin served as CEO of JMH Premium, a private equity-backed savory ingredients business. Kevin led the business through an aggressive period of growth for its private equity sponsors, and oversaw a successful exit to Southeastern Mills. Prior to JMH, Kevin held senior roles at Overhill Farms, Bellisio Foods, and Sweet Ovations, among other firms. Kevin began his career at General Mills as a Research Engineer.
Dino Eliopoulos currently serves on the Board of Directors of both Southern Veterinary Partners and SouthStar Urgent Care, and has more than 20 years of experience leading healthcare organizations. Dino is currently the Chief Executive Officer of Behavioral Innovations, one of Shore Capital's current platform investments in the autism services sector. Most recently, he was a senior vice president and Chief Financial Officer of Provista, a leading healthcare-focused performance improvement company. Prior to his role at Provista, Dino was the Chief Financial Officer of MedExpress, a multi-state urgent care company. At MedExpress, Dino expanded the company from a 4 clinic operation into to 60+ clinics with over $180 million in revenue. He was responsible for overseeing real estate activities at MedExpress, including site selection and build-out of final 40 clinics. Prior to MedExpress, Dino held various executive leadership positions with PricewaterhouseCoopers, Access Plans USA, Trinity Hospice, and Precis.
Chris Fashek is a member of the Board of Directors of Argentum Medical, a Shore Capital portfolio company.
Jim Fitzgerald is a board member of Argentum Medical, a Shore Capital portfolio company. Jim is the founder and former President and CEO of HealthTrust Purchasing Group where he oversaw its initial formation in 1999, its financial and operational functions and managed the contracting for clinical supplies, pharmaceuticals, and capital equipment, totaling approximately $20 billion annually. Jim has over 30 years of healthcare operations and leadership experience. Prior to founding HealthTrust, he served as President of HCA's Supply Chain Services, as well as several other leadership roles within HCA.
James E. Forrest currently serves as Chairman of Shore Capital, a Chicago-based private equity group focused on health care services and the food industry
Randy currently serves on the Board of Directors for Golden Bear Therapy Partners, a Shore Capital portfolio company. Randy is also the President & Co-Founder of Revolution PT and Weight Loss, based in Chicago. He founded and served as the CEO of Accelerated Rehab Centers, until the sale of Accelerated to Gryphon Investors (Accelerated would later become part of Athletico). He previously served in the Peace Corps in Bogota, Columbia.
Dr. Eugene Gabianelli, a board-certified, highly respected ophthalmologist, has practiced in Atlanta since 1992, and founded Georgia Eye Partners in 1999. His primary areas of focus are LASIK, cataract and corneal transplantation surgery. His LASIK experience began in 1995 as a co-investigator for the Summit Omnimed laser. He has extensive experience with the Nidek, Visx and Wavelight Allegretto Lasik platforms. His combined Lasik and refractive cataract surgical experience totals over 30,000 procedures. His refractive cataract practice includes all varieties of intraocular lens technology including specialty multifocal and toric lenses coupled with femtosecond laser cataract surgery. He is also active in laser vision correction following cataract surgery and corneal transplantation.
Mike George currently serves on the ClearPath Diagnostics Board of Directors. From 1998 to 2001, Mike served as the President, COO and CEO of UroCor, Inc. a 430 employee laboratory that specialized in oncology products and services for Urologists. Prior to Mike’s arrival, the company struggled to grow, was consistently unprofitable and was embroiled in a Department of Justice investigation into Medicare Fraud and Abuse. Mike successfully negotiated a settlement with the Department of Justice and returned the company to profitable growth. During Mike’s tenure the company increased revenue by 50% to $60 million and saw the stock price appreciate more than 600% with market capitalization growing from $28 million to $190 million. In addition to driving rapid growth, Mike successfully installed infrastructure and financial discipline to ensure continued revenue and earnings growth. In 2001, the company was sold to DIANON.
Joseph Giles is currently on the Board of Directors of Northeast Health Services. He previously sat on the Board of Directors for Florida Autism Center, a realized Shore portfolio company.
Brad has over 30 years’ experience in various management roles in the food, beverage and packaging sectors. Brad is the Founder and Principal at 21 Elephants LLC, an independent advisory firm providing corporate strategy, M&A, and operational improvement services. Prior to 21 Elephants, Brad led Amcor’s North American Flexible Packaging Business. His Amcor tenure also includes global leadership roles as Vice President of Corporate Development & Strategy, Director of Strategic Marketing and Director of Acquisitions and Integration and Global Director of Medical Products. Prior to his tenure at Amcor, Brad was a Senior Management Consultant within the Strategy and Process Improvement Practice at Arthur D. Little. He also served as the Global Category & Key Account Director of Beverage at Graphic Packaging International.
Phil is a national behavioral healthcare expert with over 45 years of experience. He is a featured speaker on clinical excellence and addiction treatment with keynote and panel conference presentations for the West Coast Symposium of Addiction Disorders, the National Association of Addiction Treatment Providers (NAATP), Moment of Change, and the CRC Health Group Professional Development Workshop. Most recently, Phil served as Chief Clinical Officer for CRC Health Group where he was responsible for the measurement and improvement of clinical services and the research and development of new treatment technologies. Specifically, Phil oversaw all MAT activities at CRC which was the nation’s largest provider of MAT services prior to the sale to Acadia. He also oversaw the CRC Clinical Advisory Board of distinguished healthcare industry experts. Before joining CRC in 2002, Phil served as Chief Executive Officer of Behavioral Health Concepts, a national mental health management company that he founded in 1993. He also spent eight years with Republic/OrNda Health Corporation where he developed and managed free-standing psychiatric and substance abuse treatment hospitals. Phil began his career as a Clinical Psychologist in Southern California where he practiced for 10 years.
Terry Hyman serves on the Board of Directors of EyeSouth Partners, a Shore Capital Portfolio company. Terry is the Managing Partner of Northwood Healthcare Partners, a healthcare private investment firm based in Washington, D.C. Previously, Terry served as a Managing Director of Flexpoint Ford, an industry focused private equity firm specializing in healthcare and financial services. Terry has worked with healthcare companies for 30 years, including companies in almost every sub-segment of healthcare services, including significant experience with physician practice management companies and ASCs. Terry began his career in investment banking and worked in the business for over 19 years. During his career in investment banking, Terry led the healthcare M&A business for Credit Suisse and successfully advised companies on over $20 billion of transactions.
John has extensive executive leadership experience serving the restaurant, retail, distribution and amusement park industries. John served the Wendy’s system for over 11 years, leading the launch of Wendy’s Quality Supply Chain Cooperative in January 2010, which manages over $4 billion in spend annually for Wendy’s restaurants. John’s range of executive experience - including supply chain, distribution, procurement, and operations - gives him powerful insight into every link of the foodservice industry and a keen understanding of the trends impacting the channel. Prior to joining Wendy’s QSCC, John served in the manufacturing and distribution sector as Executive Vice President and General Manager for the Commercial Division of Nice-Pak/PDI, the global expert in preventing infection and cross-contamination from bacteria in foodservice and healthcare settings. John also served as Chief Procurement Officer of U.S. Foodservice as well as Senior Vice President of Purchasing, Distribution, and Logistics for Unified Foodservice Purchasing Co-op, LLC (the co-op for Yum! Brands), where he oversaw the procurement and distribution interests of franchise and corporate stores across A&W, KFC, Long John Silver’s, Pizza Hut, and Taco Bell. John is a former member of the board of the Dave Thomas Foundation for Adoption. John previously chaired the Supply Chain Committee of the National Council of Chain Restaurants, and served on other various trade association Board and committees supporting the restaurant industry. He currently serves as Chairman of the Board for GS1 US, and is a member of the global Board for GS1.
Kevin Johnson previously sat on the Board of Directors for ClearPath Diagnostics, a realized Shore portfolio company. He has over 26 years of experience in the lab diagnostics industry. From 1996 until 2003, Kevin served as Chairman, Chief Executive Officer and President of DIANON Systems, Inc., a publicly-traded cancer diagnostic services company. During that time, DIANON grew annual revenues from approximately $56 million to approximately $200 million, and the company's market capitalization grew from $45 million to approximately $600 million when it was sold to Laboratory Corporation of America (NYSE: LH) in January of 2003. Prior to joining DIANON, Mr. Johnson was employed by Quest Diagnostics and Quest's predecessor, the Life Sciences Division of Corning, Inc., for 18 years, and held numerous management and executive level positions.
Lee Kaplan is a board member at Point C, a Shore Capital portfolio company. Lee began his career as a CPA working For Ernst and Whinney in Los Angeles. In 1985 he joined Enterprise Holdings, Inc. Enterprise operates Enterprise Rent-A-Car, Alamo Rent-A-Car, National Car Rental, Enterprise Fleet Services, and Enterprise Truck Rental through a network of 9,600 corporate and franchised locations and over 2 million vehicles throughout the world. Over his 33-year career Lee held positions as Vice-President of Finance, Corporate Risk Officer, and Chief Administrative Officer. While overseeing the Company’s Risk functions, Lee developed the self-retained risk portfolio for the world’s largest fleet including captive insurance companies, claims administration, and agency operations. Lee was also responsible for Government Relations, Legal, Mergers and Acquisitions, Corporate Venture Capital, and Strategic Planning. Lee led acquisitions of fleet companies, technology companies, and adjacent businesses in excess of $2 billion. Enterprise also developed an active Corporate Venture fund in the emerging mobility sector. Lee attended the University of California, Santa Barbara and holds a BA in Business Economics and Accounting.
Mark Kaufman is the Founder and former Chief Executive Officer of Athletico Physical Therapy (“Athletico”) and has over 22 years of experience in the physical therapy industry. Mark has grown Athletico from a single location in Chicago in 1991 to a leading physical therapy provider in the Midwest with more than 500 locations throughout 12 states. Athletico offers physical and occupational therapy, athletic training and personal fitness services. Mark also served on the Board of Directors for Excel Rehabilitation Services and Michigan Rehabilitation Specialists, a former Shore Capital backed company.
Molly Kerr currently serves on the Board of Directors of Northeast Health Services. She is a Partner at Bain and Company where she is a product leader in the Performance Improvement practice, an active contributor in the healthcare practice and a member of Bain’s training and recruiting teams. Molly joined Bain in 1996 and has since worked in healthcare, consumer products and financial services. During her career at Bain, Molly has worked with clients to develop growth strategies, evaluate acquisition targets, redesign supply chain systems and implement large scale profit improvement programs. Molly is also leader of Bain’s Service Operations product suite where she focuses on full potential programs, cost reduction and major change programs.
Gulam Khan is a board member on Innovia Medical, a Shore Capital portfolio company. He became the CEO/Co-Chairman of Cleveland-based medical device company U.S. Endoscopy in 2003 after joining the company in 2000. During his tenure as CEO, the company was recognized for several awards, including the Weatherhead 100 List of Fastest Growing Companies in Northeast Ohio (2003-2012), MDM Magazine’s 50 Medical Device Companies To Watch, and NorthCoast 99 Best Places To Work. In 2007, Gulam was honored as an Ernst & Young Entrepreneur of the Year Finalist for Northeast Ohio. In August 2012, U.S. Endoscopy was acquired by STERIS (NYSE: STE) for $270 million.
Larry Kloess serves on the Board of Directors of EyeSouth Partners, a Shore Capital Portfolio company. He is a co-founder of FKP Advisors. He also serves on the FCA Advisory Board and is a Special Operating Partner of FCA Venture Partners. Larry is a healthcare executive with over 35 years of leadership experience in hospital and physician group management. He retired from Hospital Corporation of America (HCA) in December, 2011, after 28 years of senior leadership responsibility, most recently serving as the CEO of Centennial Medical Center from 1998-2005, and then the President of HCA’s TriStar Division from 2005-2011, with operational responsibility for 20 HCA hospitals and 10 ambulatory surgery centers throughout Tennessee, Georgia, and Kentucky. Larry is board-certified in healthcare management, a Fellow in the American College of Healthcare Executives, and has been a licensed nursing home administrator.
Dr. Price Kloess serves on the Board of Directors of EyeSouth Partners, a Shore Capital Portfolio company. Dr. Kloess currently owns and serves as Medical Director at Alabama Vision & Hearing Center, a three-location practice in the Birmingham, AL area. He is a board-certified, fellowship-trained ophthalmologist specializing in blade-free all laser Custom LASIK laser vision correction, "no stitch" cataract laser and surgery, refractive lens exchange with bifocal implants, phakic IOL surgery, and corneal transplantation surgery. Dr. Kloess served as Cornea Chairman and Consultant to the USAF Surgeon General for refractive surgery for several years before returning home to Birmingham in 1994 as the founder and Medical Director of the Alabama Vision & Hearing Center. He is a Principal Investigator for the Alcon FDA Phakic IOL Study and a clinical consultant for several pharmaceutical and surgical companies. He is a fellow of the American Academy of Ophthalmology and served as President of the Alabama Academy of Ophthalmology.Dr. Kloess completed his residency training in ophthalmology at the USAF Wilford Hall Medical Center in San Antonio, TX and his fellowship training in corneal and refractive surgery at the Emory University School of Medicine.Current and Past Board RolesEyeSouth PartnersAreas of FocusEye Care Services
Jan Knysz serves on the Board of Directors of Great Lakes Dental Partners, a Shore Capital portfolio company. Previously, Jan served as Chief Operating Officer of Great Expressions Dental Centers (GEDC), a dental practice management company that grew to over 150 affiliated dental offices in seven states.